PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12891685::ACT035932

NY-ESO-1

Evidence text

Paper-level observation

The increase of NY-ESO-1 to NY-ESO-1/anti-PD-1 in R was significant, with an increase of >60% in IFNγ (Fig. 3E,F).
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
Antibacterial
Measure
fold_change
Comparator
>
Raw observation
increase of >60% in IFNγ
Normalized measurement
>60
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
SLLMWITQC
Standardization
ready simple

Source publication

Immune checkpoint inhibition increases antigen-specific T cell response in head and neck cancer

Scientific Reports · 2026

DOI 10.1038/s41598-026-38740-z PMC12891685
Parent mention

Related peptide identities

PEPDIA-PLP-002699

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.